investorscraft@gmail.com

Intrinsic ValueNippon Sanso Holdings Corporation (4091.T)

Previous Close¥4,688.00
Intrinsic Value
Upside potential
Previous Close
¥4,688.00

VALUATION INPUT DATA

This valuation is based on fiscal year data as of 2025 and quarterly data as of .

Data is not available at this time.

Stock Valuation Context

Business Model And Market Position

Nippon Sanso Holdings Corporation operates as a global industrial gas supplier, specializing in the production and distribution of oxygen, nitrogen, argon, and specialty gases like helium and hydrogen. The company serves diverse industries, including healthcare, electronics, and manufacturing, through its five regional segments: Japan, the U.S., Europe, Asia, and Oceania. Its vertically integrated model includes gas production, equipment installation, and maintenance services, ensuring steady demand across economic cycles. Nippon Sanso also maintains a niche presence in consumer goods, manufacturing vacuum-insulated bottles and kitchenware under its Thermos segment. As a subsidiary of Mitsubishi Chemical Group, it benefits from synergies in chemical and material sciences, reinforcing its competitive edge in high-purity gas applications for semiconductors and healthcare. The company’s global footprint and technological expertise position it as a key player in the industrial gas market, particularly in Asia and North America, where demand for electronic and medical gases is growing.

Revenue Profitability And Efficiency

In FY 2024, Nippon Sanso reported revenue of ¥1.26 trillion, with net income of ¥105.9 billion, reflecting a robust 8.4% net margin. Operating cash flow stood at ¥216 billion, supported by stable demand in industrial gases and efficient working capital management. Capital expenditures of ¥118.3 billion indicate ongoing investments in production capacity and technology, aligning with long-term growth in electronics and healthcare sectors.

Earnings Power And Capital Efficiency

The company’s diluted EPS of ¥244.65 underscores its earnings resilience, driven by high-margin specialty gases and geographic diversification. Return on invested capital remains healthy, supported by recurring revenue streams from long-term gas supply contracts and equipment leasing. Debt levels are manageable, with interest coverage bolstered by consistent cash flow generation.

Balance Sheet And Financial Health

Nippon Sanso’s balance sheet shows ¥126.1 billion in cash against ¥890.3 billion in total debt, reflecting a leveraged but sustainable structure. The debt is primarily long-term, mitigating near-term liquidity risks. Strong operating cash flow provides flexibility for debt servicing and strategic investments, while the Mitsubishi Chemical affiliation adds financial stability.

Growth Trends And Dividend Policy

Revenue growth is likely tied to expansion in electronics and renewable energy sectors, particularly for hydrogen and high-purity gases. The company pays a dividend of ¥48 per share, offering a modest yield, with payout ratios indicating room for incremental increases. Shareholder returns are balanced against reinvestment needs for regional expansion and R&D.

Valuation And Market Expectations

At a market cap of ¥2.15 trillion, the stock trades at a P/E of ~20x, in line with industrial gas peers. The low beta (0.49) suggests defensive characteristics, appealing to investors seeking stability in basic materials. Market expectations hinge on sustained demand for industrial gases and margin improvement in specialty segments.

Strategic Advantages And Outlook

Nippon Sanso’s strengths lie in its global scale, technological expertise, and Mitsubishi Chemical’s backing. Near-term focus includes capitalizing on semiconductor and clean energy trends, while Thermos consumer products provide diversification. Risks include input cost volatility and regional economic slowdowns, but the company’s diversified client base and contractual revenue provide resilience.

Sources

Company filings, Bloomberg

show cash flow forecast

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year2026202720282029203020312032203320342035203620372038203920402041204220432044204520462047204820492050

INCOME STATEMENT

Revenue growth rate, %NaN
Revenue, $NaN
Variable operating expenses, $mNaN
Fixed operating expenses, $mNaN
Total operating expenses, $mNaN
Operating income, $mNaN
EBITDA, $mNaN
Interest expense (income), $mNaN
Earnings before tax, $mNaN
Tax expense, $mNaN
Net income, $mNaN

BALANCE SHEET

Cash and short-term investments, $mNaN
Total assets, $mNaN
Adjusted assets (=assets-cash), $mNaN
Average production assets, $mNaN
Working capital, $mNaN
Total debt, $mNaN
Total liabilities, $mNaN
Total equity, $mNaN
Debt-to-equity ratioNaN
Adjusted equity ratioNaN

CASH FLOW

Net income, $mNaN
Depreciation, amort., depletion, $mNaN
Funds from operations, $mNaN
Change in working capital, $mNaN
Cash from operations, $mNaN
Maintenance CAPEX, $mNaN
New CAPEX, $mNaN
Total CAPEX, $mNaN
Free cash flow, $mNaN
Issuance/(repurchase) of shares, $mNaN
Retained Cash Flow, $mNaN
Pot'l extraordinary dividend, $mNaN
Cash available for distribution, $mNaN
Discount rate, %NaN
PV of cash for distribution, $mNaN
Current shareholders' claim on cash, %NaN
HomeMenuAccount